In Silico Molecular Docking Study of Hemagglutinin to Develop A Novel Anti-Influenza DrugPlay Entry Video
Meet Anika. Anika used in silico testing to develop a more effective solution to combat the Influenza virus in hopes to reduce the nearly 45 million cases and over 60,000 deaths reported annually.
Why did you enter the Young Scientist Challenge?
I have always been amazed by science experiments since my childhood and I was drawn towards finding effective cures for Influenza disease after a severe bout of the infection last year. I would like to learn more from 3M scientists to pursue my drug development and with their help, would like to conduct in-vitro and in-vivo testing of my lead drug candidate.
What is your favorite invention of the last 100 years, and why?
My favorite invention is the Internet because it allows us to explore so much with just a few clicks. I find it a treasure trove of information and it has become a valuable asset in pursuing knowledge and conducting research from anywhere and at anytime. I am amazed at how vast and profound it is and cannot imagine a world without the internet. When coupled with proper judgement and use, we can achieve so much more and I am enthused at its potential each time I use it.
In 15 years I hope to be...
a medical researcher and professor.
Never stop asking questions.